Navigation Links
Cancer cells were killed even at reduced dose of radiation therapy in early stage Hodgkin’s.

Professor Hans Theodor Eich and his colleagues from University of Cologne, Germany has found that lowering dose of radiation in Hodgkin’s Lymphoma patients undergoing chemotherapy does not increase the risk of disease //progression but benefits in reducing the side effects of radiation therapy. The results of the study were published in American Society for Therapeutic Radiology and Oncology. The researchers have reduced the radiation dosage in patients with early stage Hodgkin’s Lymphoma who were undergoing chemotherapy. The researchers feel that treating this cancer is easy in their early stage.

The researchers recruited 1,131 patients from the time period May 1998 to May 2002 who were undergoing chemotherapy for their cancer, they reduced the radiation dosage from 30 Gy to 20 Gy and the results showed no great difference in patients undertaking 30 Gy in 98 % of patients and these patients were followed up to find out whether they developed any disease recurrence. The scientists found no difference between patients taking 30 Gy and 20 Gy and it is well known that patients undergoing Radiation therapy is vulnerable to development of side effects and the patients who were given 20 Gy radiation dose developed only minimal side effects compared to patients who underwent 30 Gy.

Dr. Hans Theodor Eich said, “Although this was an interim study, the results are very encouraging that we can cure patients with early-stage Hodgkin’s lymphoma of their cancer while reducing the amount of radiation we give them, thus allowing them to have a higher quality of life after treatment.”

Source: News wse
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... ... April 29, 2016 , ... CURE Media Group , ... with cancer, today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer ... Healer® for Oncology Nursing , which honors nurses who have dedicated their careers ...
(Date:4/29/2016)... ... 29, 2016 , ... Natren, Inc. recently sent representatives to ... Petbiotics ™, as they fondly call them. As animal lovers, they were deeply ... non-profit organizations. Animal rescues across the nation face huge hurdles rescuing animals in ...
(Date:4/29/2016)... ... April 29, 2016 , ... Coalition Duchenne, ... dystrophy, and funding for Duchenne research, participated in the April 25 U.S. Food ... novel Duchenne drug eteplirsen. The meeting at the Marriott Conference Center in Hyattsville, ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... data for 2014. Each year, reproductive endocrinologists are required to report in ... main organization of professionals dedicated to the practice of assisted reproductive technologies in ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 2016 Transparency Market Research has ... - Global Industry Analysis, Size, Share, Growth, Trends, and ... global skincare devices market was valued at US$ 7,255.8 ... a CAGR of 10.1% from 2015 to 2023 to ... the full Skincare Devices Market (Treatment Device - LED Therapy ...
(Date:4/27/2016)... , April 27, 2016 ... addition of the  "Global Anesthesia Disposables Market ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ,The global anesthesia ... a CAGR of 4.03% during the period ... a major threat to patients, safety. Organizations ...
(Date:4/26/2016)... Diplomat Pharmacy, Inc. (NYSE: DPLO) is pleased ... Pharm D., to Vice President of Education and Quality. ... will continue to lead and oversee Diplomat University, an ... and training to Diplomat employees and external professionals on ... also houses the quality assurance department, which focuses on ...
Breaking Medicine Technology: